Source:http://linkedlifedata.com/resource/pubmed/id/18571420
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2008-7-25
|
pubmed:abstractText |
Various 4-(anilino)pyrrole-2-carboxamides were designed and synthesized as novel androgen receptor (AR) antagonists without steroidal or anilide structure, based on our strategy for developing full antagonists of nuclear receptors. Introduction of a bulky N-alkyl group, such as a cyclohexylmethyl or benzyl group, increased the binding affinity for wild-type AR and the potency for growth inhibition of androgen-dependent SC-3 cells. Among the compounds obtained, N-[4-[(benzyl)(4-nitrophenyl)amino]-1-methylpyrrole-2-carbonyl]pyrrolidine (22) is as potent an AR antagonist as the typical anilide-type AR antagonists hydroxyflutamide and bicalutamide. Further, compound 22 had potent binding affinity for T877A mutated AR, and dose-dependently inhibited the testosterone-induced production of prostate-specific antigen in LNCaP cells bearing T877A AR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1464-3391
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6799-812
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18571420-Androgen Antagonists,
pubmed-meshheading:18571420-Androgen Receptor Antagonists,
pubmed-meshheading:18571420-Cell Line, Tumor,
pubmed-meshheading:18571420-Humans,
pubmed-meshheading:18571420-Male,
pubmed-meshheading:18571420-Mutation,
pubmed-meshheading:18571420-Prostate-Specific Antigen,
pubmed-meshheading:18571420-Prostatic Neoplasms,
pubmed-meshheading:18571420-Protein Binding,
pubmed-meshheading:18571420-Pyrroles,
pubmed-meshheading:18571420-Receptors, Androgen
|
pubmed:year |
2008
|
pubmed:articleTitle |
4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor.
|
pubmed:affiliation |
Institute of Molecular & Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|